Please assess the completion status of the following clinical trial:

Trial Title: Microbiome and Axial Spondyloarthritis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* ICD-10 disease code or diagnosis for AxSpA~* Confirmed diagnosis of AxSpA, based on ASDAS criteria including both non-radiographic axial spondyloarthritis and ankylosing spondylitis~* HLA-B27 positive~* Signed informed consent prior to any study-specific procedures are performed~* Females and males aged 18 years or older~* Able to read, speak and understand English~* Willing and able to use the at-home collection kits and mail in pre-paid mailers~* Willing and able to use a smartphone app or web app to answer surveys~* Willing and able to make and keep/travel to a local lab visit for blood collection~* Willing and able to follow the study instructions, as described in the recruitment letter~Exclusion Criteria:~* Unable or unwilling to use Viome's App on an iPhone or Android smartphone~* Not HLA-B27 positive~* No diagnosis for AxSpA/AS~* Pregnant or nursing~* Other diagnosis of arthritis (rheumatoid, osteoarthritis, psoriatic arthritis, psoriatic spondyloarthritis)~* IBD/Crohn's disease/ulcerative colitis~* Use of antibiotics or Sulfasalazine within the past 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- All Study Participants (Type: OTHER): Enrolled with: AxSpA diagnosis, HLA-B27 positive, mASDAS \> or = 1.3 and HLA-B27 positive. Will complete surveys online or on an app, about mental and physical health and how they are doing, submits and collection of samples (blood, stool, saliva, urine, fasting blood test at local lab). Receives results of some of the analysis of samples. Participants that qualify and complete the first set of samples can be eligible for the 3 and 6 month longitudinal follow-up collection kits.~All participants receive dietary recommendations based on samples collected and the analysis of the microbiome.

Based on this trial design, predict the completion outcome and termination type (if applicable).